Related Experiment Video
Updated: May 5, 2026
09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
5.9K
[Supramolecular nanomachines for sugar responsive insulin release systems]
1Faculty of Pharmaceutical Sciences, Josai University.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|December 3, 2013
Summary
Phenylboronic acid-modified cyclodextrins (PBA-CyDs) form novel nanostructures. These supramolecular nanomachines disintegrate in response to sugar, showing potential for drug delivery systems.
Area of Science:
- Supramolecular chemistry
- Materials science
- Nanotechnology
Context:
- Cyclodextrins (CyDs) are cyclic oligosaccharides with a hydrophobic cavity, widely used in pharmaceuticals to enhance drug stability and solubility.
- Recent interest focuses on CyDs as building blocks for unique supramolecular nanostructures.
- Phenylboronic acid (PBA) modification enables covalent bonding with sugar diols, creating functionalized CyDs.
Purpose:
- To synthesize and characterize phenylboronic acid-modified cyclodextrins (PBA-CyDs).
- To investigate the self-assembly behavior and structural transformations of PBA-CyDs in response to chemical signals (sugars).
- To explore the potential of these PBA-CyD nanostructures as sugar-responsive nanomachines for applications like insulin delivery.
Summary:
- PBA-modified α- and β-cyclodextrins (PBA-α-CyD and PBA-β-CyD) were synthesized.
- PBA-α-CyD formed supramolecular polymers via intermolecular interactions, while PBA-β-CyD formed head-to-head dimers.
- Both nanostructures disintegrated upon exposure to sugars due to changes in the PBA moiety and loss of self-assembly driving force.
Impact:
- Demonstrates the creation of sugar-responsive supramolecular nanomachines using modified cyclodextrins.
- Highlights the potential for developing targeted drug delivery systems, such as a sugar-responsive insulin release system.
- Establishes a foundation for further research into PBA-CyD nanostructures for advanced biomedical applications.
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
01:05Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
01:27Insulin Formulations: Types and Delivery
1.2K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
1.2K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
2.1K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.1K
01:06Oral Hypoglycemic Agents: Glinides
1.0K
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
1.0K